IGC Pharma (IGC) Finished Goods (2020 - 2026)
IGC Pharma's Finished Goods was $191,000 in Q4 2026, down 25.4% from $256,000 a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Finished Goods (2020 - 2026) Analysis & Trends
From Q4 2020 onward, IGC Pharma has reported Finished Goods for 25 quarters.
- Finished Goods has now declined for five consecutive years, with a five-year compound annual growth rate of -28.0% (FY2021 to FY2026).
- In earlier years, Finished Goods was $256,000 in FY2025 (-42.0%), $441,000 in FY2024 (-17.3%), $533,000 in FY2023 (-25.7%) and $717,000 in FY2022 (-27.2%).
- The Q4 2026 figure marks the lowest quarterly Finished Goods in data going back to Q4 2020.
- Compared with a year earlier, Finished Goods has declined for 18 straight quarters, with an average decline of 33.6% over the last eight quarters.
- The best year-over-year quarter for Finished Goods over five years was Q1 2022 (growth of 17.2%); the worst was Q2 2026 (a decline of 47.5%).
- Per Business Quant data, IGC's Finished Goods in the three quarters before Q4 2026 was $194,000 (Q3 2026), $212,000 (Q2 2026) and $271,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 191,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 404,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 511,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 550,000.00 |
| Mar 31, 2023 | 533,000.00 |
| Dec 31, 2022 | 706,000.00 |
| Sep 30, 2022 | 801,000.00 |
| Jun 30, 2022 | 752,000.00 |
| Mar 31, 2022 | 717,000.00 |
| Dec 31, 2021 | 889,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 948,000.00 |
API Access
IGC Pharma Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();